DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,150,193 | +63.1% | 4,636 | +57.7% | 0.10% | +64.4% |
| Q2 2023 | $705,360 | +3.4% | 2,939 | +8.6% | 0.06% | -1.7% |
| Q1 2023 | $682,020 | +23.4% | 2,706 | +29.9% | 0.06% | +11.1% |
| Q4 2022 | $552,764 | +4.1% | 2,083 | +1.4% | 0.05% | -3.6% |
| Q3 2022 | $531,000 | +6.4% | 2,055 | +4.5% | 0.06% | +7.7% |
| Q2 2022 | $499,000 | -11.4% | 1,967 | +2.4% | 0.05% | 0.0% |
| Q1 2022 | $563,000 | -58.1% | 1,920 | -53.0% | 0.05% | -56.3% |
| Q4 2021 | $1,345,000 | -3.5% | 4,089 | -10.7% | 0.12% | -11.9% |
| Q3 2021 | $1,394,000 | +8.1% | 4,579 | -4.7% | 0.14% | +4.7% |
| Q2 2021 | $1,289,000 | +124.2% | 4,804 | +85.6% | 0.13% | +98.5% |
| Q4 2020 | $575,000 | +109.1% | 2,589 | -4.8% | 0.06% | -14.5% |
| Q2 2016 | $275,000 | -7.1% | 2,719 | -12.8% | 0.08% | -5.0% |
| Q1 2016 | $296,000 | +2.4% | 3,119 | -0.1% | 0.08% | +6.7% |
| Q4 2015 | $289,000 | +9.5% | 3,121 | +0.7% | 0.08% | +8.7% |
| Q3 2015 | $264,000 | -0.4% | 3,100 | 0.0% | 0.07% | -4.2% |
| Q2 2015 | $265,000 | +0.8% | 3,100 | 0.0% | 0.07% | +10.8% |
| Q1 2015 | $263,000 | -1.1% | 3,100 | 0.0% | 0.06% | -8.5% |
| Q4 2014 | $266,000 | -21.5% | 3,100 | -30.4% | 0.07% | -30.4% |
| Q3 2014 | $339,000 | -21.2% | 4,456 | -18.3% | 0.10% | -33.3% |
| Q2 2014 | $430,000 | +5.1% | 5,456 | +0.1% | 0.15% | -11.6% |
| Q1 2014 | $409,000 | -2.9% | 5,453 | 0.0% | 0.17% | -28.2% |
| Q4 2013 | $421,000 | +125.1% | 5,453 | +102.0% | 0.24% | +121.1% |
| Q3 2013 | $187,000 | +9.4% | 2,700 | 0.0% | 0.11% | +16.0% |
| Q2 2013 | $171,000 | – | 2,700 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |